Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases

NCT06567353 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06567353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06567353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 9, 2024
Completion date
December 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, liver neoplasms, metastasis